Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-31 Sale |
2024-06-03 8:00 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
2,002 | $6.09 | $12,192 | 89,471 (Direct) |
View |
| 2024-05-31 Sale |
2024-06-03 8:00 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,392 | $6.09 | $45,017 | 278,923 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:07 pm |
KALA BIO Inc. | KALA | Trachtenberg Eric SEE REMARKS |
1,227 | $6.74 | $8,270 | 88,566 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:06 pm |
KALA BIO Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
1,385 | $6.73 | $9,321 | 85,617 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:05 pm |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
1,617 | $6.74 | $10,899 | 120,773 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:04 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
4,539 | $6.73 | $30,547 | 350,815 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:04 pm |
KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
1,227 | $6.74 | $8,270 | 86,636 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:03 pm |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
1,405 | $6.74 | $9,470 | 119,087 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
60 | $28.55 | $1,713 | 11,495 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-04 Option Award |
2024-01-05 4:07 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Trachtenberg Eric SEE REMARKS |
25,100 | $0 | 88,566 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:06 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
25,100 | $0 | 85,617 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:05 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Brazzell Romulus K SEE REMARKS |
35,800 | $0 | 120,773 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:04 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
78,800 | $0 | 350,815 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:04 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
25,100 | $0 | 86,636 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:03 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
35,800 | $0 | 119,087 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director |
12,214 | $0 | 13,814 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
12,430 | $0 | 14,070 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
22,085 | $0 | 25,342 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
22,239 | $0 | 25,803 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
85,976 | $0 | 111,031 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
17,264 | $0 | 19,802 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
87,637 | $0 | 114,771 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
84,336 | $0 | 110,955 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
115,164 | $0 | 151,616 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
113,629 | $0 | 149,623 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
12,430 | $0 | 188,967 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
370,704 | $0 | 488,385 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
2,502 | $0 | 3,564 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director |
1,600 | $0 | 1,600 (Direct) |
View |
| 2022-02-15 Other |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9 | $0 | 25,064 (Direct) |
View |
| 2023-03-10 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9,625 | $0 | 25,064 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
1,738 | $0 | 2,538 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
15,639 | $0 | 27,134 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
1,640 | $0 | 1,640 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
2,197 | $0 | 3,257 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
14,736 | $0 | 26,619 (Direct) |
View |
| 2023-02-15 Other |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
73 | $0 | 8,156 (Direct) |
View |
| 2023-03-10 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
69,784 | $0 | 8,156 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
17,916 | $0 | 36,452 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
21,158 | $0 | 35,994 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
71,715 | $0 | 117,681 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
432 | $0 | 432 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
432 | $0 | 432 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
432 | $0 | 432 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
1,512 | $0 | 1,512 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
9,525 | $0 | 15,439 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
9,525 | $0 | 11,495 (Direct) |
View |